Welcome to our dedicated page for Danone news (Ticker: DANOY), a resource for investors and traders seeking the latest updates and insights on Danone stock.
Danone (DANOY), a global leader in nutrition and dairy innovation, maintains this dedicated news hub for stakeholders tracking corporate developments. Our curated collection provides immediate access to official announcements and market-moving updates from the multinational food producer.
This resource serves investors and industry observers with timely updates on financial results, product launches, and strategic partnerships. Users will find comprehensive coverage of Danone's initiatives across dairy alternatives, medical nutrition, and sustainable production practices.
The page aggregates essential updates including quarterly earnings disclosures, regulatory filings, and leadership changes. Content spans operational developments in plant-based product lines, infant nutrition research breakthroughs, and global market expansion efforts.
Bookmark this page for streamlined access to Danone's latest corporate communications. Check regularly for verified updates impacting the company's position in the competitive food and beverage sector.
Danone, a French company listed on the Paris Stock Exchange under the ticker DANOY, has released information on its total number of voting rights and shares as of July 31, 2024. The company reported a total of 679,553,991 shares outstanding. The total number of theoretical voting rights, also known as 'gross' voting rights, stands at 701,154,267. This figure is used as the basis for calculating the crossing of shareholding thresholds. The total number of exercisable voting rights, or 'net' voting rights, is 665,746,927. This information is published to ensure proper public disclosure in accordance with French regulatory requirements.
Danone has announced the public availability of its 2024 interim financial report for the six-month period ending June 30, 2024. The report is now accessible online, providing stakeholders with important financial information about the company's performance during the first half of the year. This release of the interim report is a standard practice for publicly traded companies, allowing investors and analysts to review Danone's financial position, operational results, and any significant developments that occurred during the reporting period.
Danone reported strong H1 2024 results with net sales of €13,757 million, up 4.0% like-for-like (LFL) and volume/mix up 2.1%. Despite a reported sales decline of -2.9%, operating margin rose to 12.69%, up 45 bps. Recurring EPS increased 2.6% to €1.80, while free cash flow grew by 11% to €1.2 billion. Geographical performance varied: Europe saw modest LFL sales growth of 0.7%, North America reported 5.0% LFL growth, and China/North Asia/Oceania achieved 8.4% LFL growth. Danone confirmed its 2024 guidance for LFL sales growth between 3-5% and a moderate improvement in recurring operating margin. Key developments included a €700 million bond issuance, the acquisition of Functional Formularies, and a new collaboration with Microsoft on AI initiatives.
Danone has released its latest data on voting rights and shares as of June 30, 2024. The total number of shares stands at 679,553,991. The total number of theoretical voting rights is 701,089,061, while the total number of exercisable voting rights is 665,190,317. These figures comply with Article L. 233-8 II of the French Commercial Code and Article 223-16 of the AMF General Regulation. The theoretical voting rights include all shares with voting rights, even if some are suspended, whereas exercisable voting rights exclude those with suspended voting rights.
On June 20, 2024, Danone unveiled the next phase of its Renew strategy focused on advancing health and nutrition. The company shared its mid-term strategy for 2025-2028 during a Capital Market Event, emphasizing science, innovation, operational discipline, and proactive portfolio management. Danone plans to pivot its approach to protein and gut health, expand business models in away-from-home and medical nutrition, and grow geographically. CEO Antoine de Saint-Affrique highlighted the company's transformation and commitment to delivering 3-5% net sales growth and higher recurring operating income. The event is available on Danone's website.
Danone, DMC Biotechnologies, Michelin, and Crédit Agricole Centre France have partnered to establish a state-of-the-art biotechnology platform in Clermont-Ferrand. The Biotech Open Platform, with an initial investment exceeding 16 million euros, aims to advance precision fermentation, a key biotechnological process for producing bio-based materials and ingredients. Supported by various public and private entities, this initiative seeks to scale up precision fermentation technologies from laboratory to industrial levels. By 2025, the project plans to install a demo-scale production line to enhance the development of bio-sourced materials, addressing industry needs for sustainable and innovative alternatives to fossil-based resources.
Danone disclosed the total number of shares and voting rights as of May 31, 2024. The company, listed under the stock symbol DANOY, registered a total of 679,260,800 shares. The total theoretical voting rights stood at 700,820,680, while the total exercisable voting rights were 664,921,936. These figures comply with Article L. 233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the Financial Markets Authority (AMF). The publication aims to ensure transparency in shareholder voting dynamics, differentiating between 'gross' and 'net' voting rights as recommended by the AMF.
On May 17, 2024, Danone announced it has completed the sale of its Essential Dairy and Plant-based (EDP) business in Russia to Vamin R This follows the initial announcement on March 22, 2024, confirming the receipt of required Russian regulatory approvals for the transaction. The divestment is part of Danone's broader strategic initiative to streamline its portfolio and focus on key growth areas.
Danone has reported the total number of voting rights and shares as of April 30, 2024. The company, listed in Paris, has a capital of €169,443,282 and is registered under the number 552 032 534. As per the report, Danone has 677,773,128 shares. The total number of theoretical voting rights is 698,764,592, while the total number of exercisable voting rights is 662,863,346. The theoretical voting rights include all shares, even those with suspended voting rights, while the exercisable voting rights exclude such shares, adhering to AMF guidelines.
Danone has acquired Functional Formularies, a whole foods tube feeding business in the US, to strengthen its Medical Nutrition portfolio and expand its enteral tube feeding ranges as part of the Renew Danone strategy. This acquisition adds a differentiated product portfolio to support the nutritional needs of tube-fed families and patients.
